S100A8 and neoplasm: MCAM has also been described as a co‐receptor for several growth factor receptors such as VEGFR2 or PDGFR‐β or inflammatory mediators such as S100A8/A9, and may thereby promote cell growth and simulate tumour vascularisation [31, 32, 33, 34, 35].